the aid library

LIST OPTIONS

Filter

3851

Download (1050)

View PDF (1249)

Philippine Practice Guidelines on the Diagnosis and Management of Diabetes Mellitus

UNITE FOR DIABETES PHILIPPINES (2010) C1

Download (442)

View PDF (373)

Recommendations for Implementing Antimicrobial Stewardship Programs in Latin America and the Caribbean: Manual for Public Health Decision-Makers

Pan American Health Organization PAHO (2018) C2

As a public good, antimicrobial medicines require rational use if their effectiveness is to be preserved. However, up to 50% of antibiotic use is inappropriate, adding considerable costs to patient care, and increasing morbidity and mortality. In addition, there is compelling evidence that antimicro... more

Download (407)

View PDF (386)

Rwanda Demographic and Health Survey 2014-15

National Institute of Statistics of Rwanda (NISR) [Rwanda], Ministry of Health (MOH) [Rwanda], and ICF International. (2015) C2

The main objective of the 2014-15 RDHS was to obtain current information on demographic and health indicators, including family planning; maternal mortality; infant and child mortality; nutrition status of mothers and children; prenatal care, delivery, and postnatal care; childhood diseases; and ped... more

Download (325)

View PDF (418)

Improving Brain Tumor Research in Resource-Limited Countries: A Review of the Literature Focusing on West Africa

S. I. Ngulde; F. Fezeu; A.Ramesh; et al. PMC; Cureus (2015) C2

Cureus. 2015 Nov; 7(11): e372. Published online 2015 Nov 3. doi: 10.7759/cureus.372 PMCID: PMC4671837 PMID: 26677422

Download (264)

View PDF (413)

Sahel Crisis 2020: Responding to the urgent needs of refugees, internally displaced, returnees and others of concern (June 2020)

UN High Commissioner for Refugees UNHCR (2020) CC

he central Sahel region—Burkina Faso, Mali and Niger—is facing a severe humanitarian and protection crisis. Massive displacement, most of it driven by intense and largely indiscriminate violence perpetrated by a range of armed actors against civilian populations, is taking place across the regi... more

Download (291)

View PDF (357)

Imaging ultrasound before 24 weeks of pregnancy: 2022 update to the WHO antenatal care recommendations for a positive pregnancy experience

World Health Organization WHO (2022) C_WHO

This technical brief describes the re-affirmed WHO recommendation on ultrasound examination in the context of routine antenatal care and outlines policy and programme implications for translating this recommendation into action at the country level.

Download (244)

View PDF (394)

Social network methods for HIV case-finding among people who inject drugs in Tajikistan

M. Kan; D. B. Garfinkel; O. Samoylova; et al. Journal of the International AIDS Society (2018) C2

Kan M et al. Journal of the International AIDS Society 2018, 21(S5):e25139 http://onlinelibrary.wiley.com/doi/10.1002/jia2.25139/full | https://doi.org/10.1002/jia2.25139

Download (274)

View PDF (410)

Protocol to investigate non-seasonal influenza and other emerging acute respiratory diseases

World Health Organization WHO (2018) C_WHO

Download (1113)

View PDF (1014)

National Drug Distribution Guidelines 2nd Edition 2012

Federal Ministry of Health, Nigeria (2012) C1

External Link

Recomendaciones provisionales sobre el uso de la vacuna CanSinoBIO Ad5-nCoV-S [‎recombinante]‎ (‎Convidecia™)‎ contra la COVID-19: orientaciones provisionales, primera publicación: 19 de mayo de 2022

World Health Organization WHO (2022) CC

Organización Mundial de la Salud. (‎2022)‎. Recomendaciones provisionales sobre el uso de la vacuna CanSinoBIO Ad5-nCoV-S [‎recombinante]‎ (‎Convidecia™)‎ contra la COVID-19: orientaciones provisionales, primera publicación: 19 de mayo de 2022.

Download (491)

View PDF (698)

Poverty and Risky Sexual Behaviors: Evidence from Tanzania

Silas, Joel ICF International (2013) C2

DHS Working Papers No. 88 education, wealth, mobility, employment, and media exposure

Download (437)

View PDF (544)

Algorithm for laboratory diagnosis and treatment-monitoring of pulmonary tuberculosis and drug-resistant tuberculosis using state-of-the-art rapid molecular diagnostic technologies

World Health Organization (2017) C_WHO

Expert opinion of the European Tuberculosis Laboratory Initiative core group members for the WHO European Region.

Download (1805)

View PDF (1359)

Guidebook on ICD10
recommended

Ministry of Health and Family Welfare Government of the People's Republic of Bangladesh (2015) C1

3rd edition

Download (347)

View PDF (495)

Investment guidelines for youth in agrifood systems in Africa

Food and Agriculture Organization of the United Nations FAO and African Union AU (2022) C1

The Investment guidelines for youth in agrifood systems in Africa, developed jointly by FAO and the African Union Commission (AUC) through a multi-stakeholder and participatory process, highlight the importance of youth as change agents and key stakeholders contributing to sustainable agrifood syste... more

Download (434)

View PDF (660)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Download (1360)

View PDF (2523)

Reproductive Health Assessment Toolkit for Conflict-Affected Women (Cover)

Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, Coordinating Center for Health Promotion, Centers for Disease Control and Prevention, Department of Health and Human Services, (2007)

This is only the cover of the book. Download the whole Toolkit at: www.cdc.gov/reproductivehealth/Refugee/ Understanding the reproductive health needs of conflict-affected women will enable organizations to implement and enhance programs and services to improve the health of women and their fam... more